NYSE:MG

Mistras Group Stock News

Industrials > Security & Protection Services

Buy MG

*Your capital is at risk

$15.21

+0.0400 (+0.264%)

At Close: Jul 31, 2026

MISTRAS Announces First Quarter 2025 Results

05:55pm, Wednesday, 07'th May 2025

Reinvigorated senior leadership with recently on-boarded, high-caliber positions with proven industry experience, to focus on delivering value to customers

MISTRAS Group Announces Conference Call to Discuss First Quarter Results on May 8, 2025

04:35pm, Monday, 05'th May 2025

PRINCETON JUNCTION, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (MG: NYSE) has scheduled a conference call for Thursday, May 8, 2025, at 9:00 am Eastern Standard Time to present its res

FDA Approves Johnson & Johnson's IMAAVYTM (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families

01:42pm, Wednesday, 30'th Apr 2025

First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older. First and only FcRn blocker approved in anti-AChR and anti-MuSK a

MISTRAS Group Launches MISTRAS Data Solutions Brand, Integrating Data-driven Capabilities for Customers Worldwide

08:00am, Thursday, 24'th Apr 2025

PRINCETON JUNCTION, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG), the leading global provider of integrated, technology-enabled asset protection solutions, today announced t

MISTRAS Group Names Aerospace & Defense Leader Cliff Schaffer as SVP of In-Lab Services

08:30am, Monday, 14'th Apr 2025

PRINCETON JUNCTION, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG), the leading provider of integrated technology-enabled asset protection solutions, today announced the appoi

MISTRAS Group Rings Bell at NYSE, Reaffirming Its Leadership in Data-Driven Asset Protection

08:00am, Wednesday, 09'th Apr 2025

PRINCETON JUNCTION, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG), the leading “one source” multinational provider of integrated technology-enabled asset protection solut

Mistras (MG) Surges 5.7%: Is This an Indication of Further Gains?

12:10pm, Monday, 24'th Mar 2025

Mistras (MG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the

Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

07:45am, Wednesday, 19'th Mar 2025

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported

Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

07:45am, Wednesday, 19'th Mar 2025

Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

04:32pm, Tuesday, 18'th Mar 2025

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announce

Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

04:32pm, Tuesday, 18'th Mar 2025

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by